Detalhe da pesquisa
1.
The National Lung Matrix Trial of personalized therapy in lung cancer.
Nature
; 583(7818): 807-812, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32669708
2.
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer.
Nature
; 585(7826): E21, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32887973
3.
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer.
Eur Radiol
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38388716
4.
REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment.
Lancet Oncol
; 24(5): e219-e227, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142383
5.
Revitalising cancer trials post-pandemic: time for reform.
Br J Cancer
; 128(8): 1409-1414, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36959378
6.
Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes.
Br J Cancer
; 128(2): 342-353, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36402875
7.
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial.
Lancet Oncol
; 23(4): 540-552, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358455
8.
Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action.
Eur J Immunol
; 51(3): 544-556, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33450785
9.
18F FDG PET/CT and Novel Molecular Imaging for Directing Immunotherapy in Cancer.
Radiology
; 304(2): 246-264, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762888
10.
Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies.
Clin Exp Immunol
; 209(1): 4-21, 2022 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020853
11.
Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patients.
Clin Exp Immunol
; 207(1): 84-94, 2022 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020866
12.
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.
Lancet Oncol
; 22(6): 765-778, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33930323
13.
Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.
Br J Cancer
; 125(7): 939-947, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34400804
14.
Acoustics at the nanoscale (nanoacoustics): A comprehensive literature review.: Part I: Materials, devices and selected applications.
Sens Actuators A Phys
; 332(Pt 2)2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937991
15.
Acoustics at the nanoscale (nanoacoustics): A comprehensive literature review.: Part II: Nanoacoustics for biomedical imaging and therapy.
Sens Actuators A Phys
; 332(Pt 2)2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937992
16.
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.
Lancet Oncol
; 21(8): 1023-1034, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702310
17.
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial.
Lancet Oncol
; 20(3): 383-393, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745090
18.
A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer.
Breast Cancer Res
; 22(1): 1, 2019 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31892325
19.
Supercontinuum-laser diffuse reflectance spectroscopy in conjunction with an extended Kubelka-Munk model-a methodology for determination of temperature-dependent quantum efficiency in highly scattering and fluorescent media.
Appl Opt
; 58(10): 2438-2445, 2019 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31045035
20.
The Evolving Landscape of Cancer Therapeutics.
Handb Exp Pharmacol
; 260: 43-79, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31792681